CTRI/2023/04/051670招募中3 期
Efficacy of Ayurveda interventions (Hridyarnava Rasa and Harityakyadi yoga) as an add-on to standard care in Stable Coronary Artery Disease (CAD) assessed through Global Longitudinal Strain Imaging Technique (GLSIT) - A Randomized Controlled Trial - CAD
Central Council for Research in Ayurvedic Sciences (CCRAS) (Ministry of AYUSH Govt. of India)0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patients of either sex aged 35-75 years
- •2.Subjects diagnosed with stable coronary artery disease (CAD) having GLS value poor than -14
- •3.Patients willing to participate in the study for 30months.
排除标准
- •1.Subjects with history of Coronary Artery Bypass Grafting (CABG) and percutaneous trans luminal coronary angioplasty (PTCA);
- •2.Subjects with symptomatic CAD (Chest pain at Rest);
- •3.Subjects with recent acute coronary syndrome (within last 3 months);
- •4.Subjects with congestive cardiac failure;
- •5.Subjects with anomalies of coronary arteries, valvular heart disease, cardiac arrhythmias;
- •6.Subjects with uncontrolled hypertension (BP = 180/100 mm Hg);
- •7.Subjects with history of CVA/Stroke (within six months)
- •8.Subjects with history of coagulation disorders
- •9.Subjects with History of uncontrolled Diabetes Mellitus with HbA1c = 10
- •10.History of Pulmonary dysfunction, psychiatric illness, HIV infection or any other comorbidities
- •11. Subjects with BMI = 35 kg/m2
- •12.Subjects with history of active malignancy;
- •13.Subjects with Serum TSH =10µIU/ml with or without medication.
- •14.Subjects with serum creatinine level = 1.2 mg/dL, chronic kidney disease (GFR < 60 ml/min),
- •15.Subjects with abnormal Liver Function Test (LFT) with values more than two times the upper limit of normal;
- •16.Subjects on corticosteroids, immunosuppressive drugs or any other medication which from the investigator’s viewpoint may not be suitable for the study participation;
- •17.Subject with history of chain smoking, alcohol or substance abuse
- •18.Subjects with suspected hypersensitivity to any of the ingredients of study medication;
- •19.Subjects with concurrent participation in another clinical trial or any investigational therapy within 30 days prior to signing informed consent;
- •20.Female subjects who are pregnant or lactating or planning to conceive during the study period. Females who are not ready to use acceptable contraceptive methods during the course of study;
- •21.Any condition that the investigator thinks may jeopardise the study.
研究者
相似试验
尚未招募
3 期
A clinical study on Efficacy of Ayurveda intervention on Stable coronary Artery DiseaseCTRI/2024/02/062553Central Council for Research in Ayurvedic Sciences
已完成
2 期
Effect of AYUSH 64 in COVID 19CTRI/2020/06/025855IPGT and RA80
尚未招募
3 期
Ayurvedic management of polycystic ovarian syndrome in adolescents and young adultsCTRI/2023/03/050440Archana S
尚未招募
2 期
A Clinical trial to study the effect of selected Ayurveda procedures & physiotherapy in spastic cerebral palsyCTRI/2023/10/059262Dr Suneetha.R
尚未招募
2 期
A clinical trial to study the effectiveness of selected Ayurvedic treatment protocol in type 2 Diabetes MellitusCTRI/2024/07/070666Dr Aysha Subinam S